Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
01 4Granules India Limited
02 2SYNTHOKEM LABS PRIVATE LIMITED
03 1Synthokem Labs Private Limited
04 1Delta Synthetic Co. Ltd
05 1KRS PHARMACEUTICALS
06 1Kalchem International inc
07 1LETCO MEDICAL, LLC
08 1Medisca Inc.
09 1Professional Compounding Centers of America dba PCCA
10 1Seven Star Pharmaceutical Co., Ltd.
11 1Smilax Laboratories Limited
12 1Spectrum Laboratory Products, Inc.
13 1Zen Chemicals Private Limited
14 1Zhejiang Haizhou Pharmaceutical Co., Ltd.
01 4GUAIFENESIN
02 2GUAIFENISIN
03 10Guaifenesin
04 1Guaifenesin Directly compressible Granules 95%
05 1Guaifenesin Directly compressible granules 95%
01 1China
02 9India
03 1Japan
04 2Taiwan
05 4U.S.A
06 1United Kingdom
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
NDC Package Code : 62207-500
Start Marketing Date : 2017-08-17
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (95mg/100mg)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 58343-0130
Start Marketing Date : 2013-11-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
NDC Package Code : 62207-503
Start Marketing Date : 2012-05-04
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (95mg/100mg)
Marketing Category : DRUG FOR FURTHER PROCESSING
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
NDC Package Code : 62207-932
Start Marketing Date : 2021-12-17
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : EXPORT ONLY
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
NDC Package Code : 62207-950
Start Marketing Date : 2013-04-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : EXPORT ONLY
NDC Package Code : 58343-0132
Start Marketing Date : 2012-11-11
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 58343-0136
Start Marketing Date : 2012-11-11
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 38779-0696
Start Marketing Date : 2012-04-24
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 51927-1147
Start Marketing Date : 2002-07-19
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 49452-3420
Start Marketing Date : 1986-03-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
A Guaifenesin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Guaifenesin, including repackagers and relabelers. The FDA regulates Guaifenesin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Guaifenesin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Guaifenesin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Guaifenesin supplier is an individual or a company that provides Guaifenesin active pharmaceutical ingredient (API) or Guaifenesin finished formulations upon request. The Guaifenesin suppliers may include Guaifenesin API manufacturers, exporters, distributors and traders.
click here to find a list of Guaifenesin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Guaifenesin as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Guaifenesin API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Guaifenesin as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Guaifenesin and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Guaifenesin NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Guaifenesin suppliers with NDC on PharmaCompass.
We have 13 companies offering Guaifenesin
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?